Tackling the cytokine storm in COVID-19, challenges and hopes
The outbreak of Coronavirus disease 2019 (COVID-19) is the current world health concern,
presenting a public health dilemma with ascending morbidity and mortality rates exceeding …
presenting a public health dilemma with ascending morbidity and mortality rates exceeding …
[HTML][HTML] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta …
BM Henry, MHS De Oliveira, S Benoit… - Clinical Chemistry and …, 2020 - degruyter.com
Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …
need for identification of clinical and laboratory predictors for progression towards severe …
The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro …
Objectives Severe coronavirus disease 2019 (COVID-19) is associated with a dysregulated
immune state. While research has focused on the hyperinflammation, little research has …
immune state. While research has focused on the hyperinflammation, little research has …
Prognostic value of inflammatory biomarkers in patients with severe COVID-19: A single-center retrospective study
Background: The current knowledge about novel coronavirus-2019 (COVID-19) indicates
that the immune system and inflammatory response play a crucial role in the severity and …
that the immune system and inflammatory response play a crucial role in the severity and …
What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
It remains important to investigate the changing and impact of routine blood values (RBVs)
in order to predict mortality and follow an appropriate treatment in COVID-19 patients. In the …
in order to predict mortality and follow an appropriate treatment in COVID-19 patients. In the …
The looming storm: blood and cytokines in COVID-19
A novel coronavirus termed as COVID-19 by WHO has been the causative agent of an
unprecedented pandemic in the history of humanity. The global burden of mortality and …
unprecedented pandemic in the history of humanity. The global burden of mortality and …
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
S Makaremi, A Asgarzadeh, H Kianfar… - Inflammation …, 2022 - Springer
A global pandemic has erupted as a result of the new brand coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic has been consociated …
respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic has been consociated …
Immune correlates of COVID-19 control
B Poonia, S Kottilil - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 caused by SARS CoV2 emerged in China at the end of 2019 and soon become a
pandemic. Since the virus is novel, pre-existing CoV2-specific immunity is not expected to …
pandemic. Since the virus is novel, pre-existing CoV2-specific immunity is not expected to …
Cytokine profile and disease severity in patients with COVID-19
Cytokine dysregulation is the proposed mechanism for Coronavirus disease 2019 (COVID-
19). The aim of this study was to evaluate the serum levels of interferon (IFN)-γ, interleukin …
19). The aim of this study was to evaluate the serum levels of interferon (IFN)-γ, interleukin …
[PDF][PDF] Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
Q Li, W Xu, WX Li, CL Huang… - European Review for …, 2020 - europeanreview.org
OBJECTIVE: We aimed to study the dynamics of cytokines and lymphocyte subsets and their
correlation with the prognosis of patients with severe COVID-19. PATIENTS AND …
correlation with the prognosis of patients with severe COVID-19. PATIENTS AND …